IJ
Innovative Health Initiative Joint Undertaking (IHI JU)

Leveraging Europe's Expertise to accelerate Cell Therapy for Type 1 Diabetes

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Legal entities established in the UK and Canada are explicitly not eligible to receive funding on this topic. The short first-stage proposal is capped at 20 pages and the full second-stage proposal at 50 pages, and consortia must meet the IHI's own additional eligibility criteria, including a roughly 45 percent industry contribution. This topic is explicitly exempted from the IHI's usual condition…

This topic wants a standardised framework for beta-cell therapy impurity thresholds and manufacturing practice, validated immune-modulating strategies that improve graft survival, and scalable, cost-effective production processes that support regulatory approval and reimbursement. It also wants AI-driven predictive models and improved preclinical models covering diverse patient groups.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.€37.2M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides β†’
IJ
Open

An AI Foundation Toxicology Model and Framework to Support Waiving a Second Species in Drug Safety Studies

πŸ‡¨πŸ‡¦IHI JU Β· European Union

Funds development of an AI toxicology model that lets drug developers waive costly second-species animal safety testing.

MedtechAI
€9MOct'26
IJ
Open

Decode the Immunoscience of age-related diseases

πŸ‡ͺπŸ‡ΊIHI JU Β· European Union

Funds a research consortium that studies why immune-mediated diseases behave differently when they first strike older adults and hunts for biomarkers to predict them.

BiotechMedtech
€9.2MOct'26
IJ
Open

IHI European HealthCare Incubator Network

πŸ‡¨πŸ‡¦IHI JU Β· European Union

Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.

MedtechBiotech
€35MOct'26
IJ
Closed

AI-Powered Signal Detection in Pharmacovigilance

πŸ‡ͺπŸ‡ΊIHI JU Β· European Union

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

MedtechAI
€8.9M
IJ
Closed

Boosting innovation for a better understanding of the determinants of health

πŸ‡ͺπŸ‡ΊIHI JU Β· European Union

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Medtech
€8M – €30M
IJ
Closed

Boosting innovation for better assessment of the added value of innovative integrated healthcare solutions

πŸ‡ͺπŸ‡ΊIHI JU Β· European Union

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Medtech
€5M – €9.8M
EttevΓ΅tluse ja Innovatsiooni Sihtasutus (EIS) logo
Open

Horizon Europe EIC Accelerator β€” Estonian Applicant Support

πŸ‡ͺπŸ‡ͺEIS Β· Estonia

Funds research teams and institutions for Horizon Europe EIC Accelerator Estonian Applicant Support in artificial intelligence, biotechnology, and climate technology.

AIBiotech+12
€2.5M
European Commission logo
Scheduled

Independent Living and Inclusion for Persons with Disabilities

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.

MedtechBiotech
€6M – €8MApr'27
European Commission logo
Scheduled

Towards Artificial General Intelligence (AGI) for healthcare

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds a European community and roadmap for trustworthy frontier AI models in healthcare.

AIBiotech+1
€2.9MSep'27
European Commission logo
Scheduled

AI Predictive Biomarkers for Chronic Diseases

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds trustworthy AI biomarker methods that predict chronic-disease progression and treatment response for personalised care.

MedtechBiotech+1
€6M – €8MApr'27
European Commission logo
Scheduled

Horizon Health: Cell-Free Protein Synthesis Platforms

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds €6–8M projects that make cell-free protein synthesis practical for discovering and producing peptide- and protein-based biologicals.

BiotechMedtech
€6M – €8MApr'27
European Innovation Council logo
Open

EIC Pathfinder Challenge: Biotechnology for Healthy Ageing

πŸ‡ͺπŸ‡ΊEIC Β· European Union

Supports translating decades of ageing biology into biotech or pharma proofs-of-concept that prevent, delay or revert age-related disease.

BiotechMedtech+1
€4MOct'26